Frost, Sophia (2015) RIT-NMAT: A New Hope for High-Risk Lymphoma Patients. Science Spotlight, 5 (1).
Preview |
Text
RIT-NMAT- A New Hope for High-Risk Lymphoma Patients.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (315kB) | Preview |
| Item Type: | Article or Abstract |
|---|---|
| Additional Information: | Cassaday RD, Storer BE, Sorror ML, Sandmaier BM, Guthrie KA, Maloney DG, Rajendran JG, Pagel JM, Flowers ME, Green DJ, Rezvani AR, Storb RF, Press OW, Gopal AK. 2014. Long-term outcomes of patients with persistent indolent B-cell malignancies undergoing nonmyeloablative allogeneic transplantation. Biol Blood Marrow Transplant. [Epub ahead of print] See also: Gopal AK, Guthrie KA, Rajendran J, Pagel JM, Oliveira G, Maloney DG, Matesan MC, Storb RF, Press OW. 2011. 90Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma. Blood. 118(4):1132–1139. |
| Collections: | Science Spotlight |
| Depositing User: | Users 60 not found. |
| Date Deposited: | 10 Apr 2015 22:32 |
| Last Modified: | 10 Apr 2015 22:32 |
| URI: | http://authors.fhcrc.org/id/eprint/955 |
Repository Administrators Only
 |
View Item |
